97 research outputs found

    Pathogenetic Grounds of Principles of Depotentiation of Lethal Effects <i>Y. pestis</i> toxins

    Get PDF
    Lethal combination of lypoplyssacharide and mouse Y. pestis toxin is decreased by the use of effective preparation - Cytoflavinum, the antihypoxant of substrate and regulatory activity. The positive resolving impact to the lethal activity of toxins of plague microbe provides also Emoxipinum, the synthetic preparation, the effect of which is enhanced by the use of Contrykal, Klexan, hemodez

    Development of ideas about professions close by their social environment in preschoolers with intellectual disability via a plot based role-playing game

    Get PDF
    Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ Ρ€Π°ΡΡΠΌΠ°Ρ‚Ρ€ΠΈΠ²Π°ΡŽΡ‚ΡΡ прСдставлСния ΠΎ профСссиях Π±Π»ΠΈΠ·ΠΊΠΈΡ… ΠΏΠΎ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΌΡƒ ΠΎΠΊΡ€ΡƒΠΆΠ΅Π½ΠΈΡŽ Ρƒ дошкольников с умствСнной ΠΎΡ‚ΡΡ‚Π°Π»ΠΎΡΡ‚ΡŒΡŽ ΠΈ направлСния Ρ€Π°Π±ΠΎΡ‚Ρ‹ ΠΏΠΎ ΠΈΡ… ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡŽ срСдствами ΡΡŽΠΆΠ΅Ρ‚Π½ΠΎ-Ρ€ΠΎΠ»Π΅Π²ΠΎΠΉ ΠΈΠ³Ρ€Ρ‹.The article is devoted to the study of the ideas about professions in preschoolers with intellectual disability, which is undoubtedly urgent in the search for effective approaches to their development and social support. The ideas about the professions close by their social environment were developed in the process of playing, in particular, in plot based role-play games

    Composition, stability, and structure of Cu(II), Ni(II), and Co(II) complexes with adipic acid dihydrazide in aqueous and aqueous-ethanol solutions

    Get PDF
    Solvation and complexation of Cu(II), Ni(II), and Co(II) with adipic acid dihydrazide (L) in aqueous and aqueous-ethanol solutions (ethanol mole fraction 0.07-0.68) were studied by spectrophotometry. The formation constants of the species M(LH)3+, ML2+, M2L4+ (ΞΌ = Cu2+, Ni2+, Co2+), and also M2L 2 4+ and ML 2 2+ (ΞΌ = Cu 2+, Ni2+) were determined. With Cu(II), the complexes Cu(LH) 2 4+ , CuL(LH)3+, and Cu 2L(LH)5+ were also detected and characterized. Evidence is given for the hydrazide coordination mode: tridentate in ML2+, bidentate in M(LH)3+ and ML 2 2+ , and tetradentate in M2L4+ and M2L 2 4+ . The ligand exchange reactions involving CuL2+, Cu(LH)3+, Cu(LH) 2 4+ , CuL(LH)3+, CuL 2 2+ , and Cu2L(LH)5+ in aqueous solutions of Cu(II) were revealed and kinetically characterized by nuclear magnetic relaxation. The heretofore unknown rate constants of formation of these complexes were calculated from the thermodynamic and kinetic parameters. Factors controlling the rate constants of the complex formation and chemical exchange are discussed. Β© Pleiades Publishing, Inc., 2006

    Smectite-bearing clays of the Middle Eocene Kievskaya Formation in the Russian Plate and their genesis

    Get PDF
    The component composition and specific features of the structure of smectite-bearing clays in the Middle Eocene Kievskaya Formation of the Russian Plate were studied by the scanning electron microscopic, X-ray phase analysis, and complete chemical analysis methods. The clays are characterized by metastable (unstable) state of material expressed as abundance of the semidissolved clasts of felsic volcanic ashes and radiolarian skeletons, as well as colloidal segregations of siliceous, aluminosiliceous (Al-Si) and ferroaluminosiliceous (Fe-Al-Si) gel-type materials and newly formed smectite. Three stages of the diagenetic alteration of Middle Eocene dacite ashes are identified. Mechanism of the further transformation of rocks into smectite clays with siliceous nodules is proposed. The viewpoint suggesting the volcanosedimentary origin of clays of the Kievskaya Formation is confirmed. Sources of the pyroclastic material (suppliers of material for clays) in the Kievskaya Formation could be related to active explosions in the Caucasian volcanic arc in the Middle Eocene. Β© 2012 Pleiades Publishing, Ltd

    Complexation and ligand exchange in aqueous of Cu(II) and Ni(II) with hydrazides of some aromatic acids

    Get PDF
    Solvation and complexation of Cu(II) and Ni(II) with benzoic (Lβ€²), p-methoxybenzoic (Lβ€³), and isonicotinic (L) acid hydrazides in aqueous-ethanol solutions (ethanol mole fraction 0.07-0.68) were studied by pH-metry, spectrophotometry, and nuclear magnetic relaxation. The formation constants of the species M(Lβ€²)2+, M(Lβ€²) 2 2+ , M(Lβ€³)2+, M(Lβ€³) 2 2+ , M(LH)3+, M(L)2+, M(L)(LH)3+, and M(L) 2 2+ , where M = Cu2+ and Ni2+, were determined. With isonicotinic acid hydrazide, a change in the coordination mode was observed in an isomer of Cu(L) 2 2+ , with one of the ligands coordinating in the bidentate fashion, and the other, in the monodentate fashion via the pyridine nitrogen atom. The suggested structures were confirmed by analysis of the parameters of the ESR and electronic absorption spectra of the complexes. The rate constants of ligand exchange and formation of the complexes Cu(Lβ€²)2+, Cu(Lβ€²) 2 2+ , Cu(Lβ€³)2+, and Cu(Lβ€³) 2 2+ in aqueous solutions were determined from nuclear magnetic relaxation measurements; the reactions occur by the associative mechanism. A cyclic process of reduction of Cu(II) to colloidal copper in the presence of Lβ€³ and atmospheric oxygen is described. Β© Pleiades Publishing, Inc., 2006

    Cyrillic Manuscript Heritage: Vol. 38

    Get PDF
    CMH 38 cover design based on the cover design of CMH 34 created by Eva Dujardin Dale.Biannual newsletter of the Hilandar Research Library (HRL) and the Resource Center for Medieval Slavic Studies (RCMSS), The Ohio State University. Includes: features by guest contributors, which may appear under the column heading of "HRL Journal" – where Cyrillic Manuscript Heritage asks researchers who have used the resources of the HRL in the past year to describe their experience and work; a column, "Director's Desk," by the Director of RCMSS; "RCMSS & HRL News Notes," i.e., reports on recent visitors, research, events, exhibits, projects, updates, etc.; contributors to both the Hilandar Endowment Fund and Hilandar's Friends of the Library Fund are listed, as are donors of "Gifts in Kind." Also included may be seasonal announcements regarding the International Hilandar Conference series and the Medieval Slavic Summer Institute.Front cover image: SPEC.OSU.HRL.GMS.FRAG.2, two sides of a single vellum leaf from a Byzantine Greek Gospel lectionary, purchased by the HRL with donations made to the Hilandar Endowment Fund and Hilandar Friends of the Library funds by Frances Roslovic, the Ostich Family, and Sharon Fullerton Maliska; Table of Contents, masthead, front cover photo caption, p. 2; "From the Director's Desk" by Dr. Predrag Matejic, p. 3; "Our Visitors": "A Blast from the Past," photo by Jessi Jones, "A Family Affair" and "HRL Public Lecture on Ivan the Terrible," photos by Jessi Jones, and photo by Georgios Anagnostou of Dr. William Kaldis and his daughter Maria Kaldis Arend, p. 4; "A Special Chaplains' Visit to the HRL" and "An Undergraduate Class Visit," photos by Jessi Jones, p. 5; "All in the Family: A Research Visit from an Alumna of MSSI 2001" by Monica White, photo courtesy of M. White, pp. 6, 8; "'Approaches to the Editing of Slavonic Texts' Workshop in Regensburg, Germany" by Susana Torres Prieto, photos courtesy of S. Torres Prieto, pp. 7-8; Unnumbered insert: recto - "In Memoriam: Professor Charles Edward Gribble," based on an obituary written by Daniel E. Collins, photo courtesy of the OSU department of Slavic and East European Languages and Cultures, and verso: Medieval Slavic Summer Institute 2017 announcement, photos by Jessi Jones; "HRL Journal: Accessing the Forbidden" by Kristina Nikolovska, photo courtesy of K. Nikolovska, p. 9; "Catching up with our MSSI Alumni," photos courtesy of Michael Furman, Alice Sullivan, and Federica Candido, p. 10; "HRL Journal: Examining the Serbian Euchologion" by Tatiana Afanas'eva, photo courtesy of T. Afanas'eva, p. 11; "HRL Journal: My First Trip to the U.S." by Marta PeΓ±a Escudero, photos courtesy of M. PeΓ±a Escudero, pp. 12, 14; "Manuscript Marginalia Lecture by Dr. Nikolovska," photo by Jessi Jones, p. 13; "A Step into Sociology: Slovene Scholars' Lecture," photos by Jessi Jones, p. 13; "In Memoriam: Protinica Ljubica Matejic," photo courtesy of Nenad Matejic, p. 14; Contributions to the Hilandar Endowment Fund, Gifts through Friends of the Library, and Gifts-in-Kind to the Hilandar Research Library, p. 15; back cover, birth announcement of Predrag Matejic's granddaughter, Elisaveta Todora Matejic, photo courtesy of Svetoslav and Sarah Matejic

    ВозмоТности противовирусной ΠΈ ΠΈΠΌΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰Π΅ΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π² Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ Π³Ρ€ΠΈΠΏΠΏΠ°, ΠžΠ Π’Π˜, гСрпСсвирусных ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΉ

    Get PDF
    Currently, acute respiratory infection (ARI) and Herpes virus infection are widely prevalent in children and adults. Clinical presentations and course,Β characterization of ARI and Herpes virus infection, groups of immunomodilating drugs and current individualized treatment approach are reviewedΒ in this article.ΠžΡΡ‚Ρ€Ρ‹Π΅ рСспираторныС вирусныС (ΠžΠ Π’Π˜) ΠΈ гСрпСсвирусныС ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ стали ΠΎΠ΄Π½ΠΈΠΌΠΈ ΠΈΠ· самых распространСнных Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ как срСди Π΄Π΅Ρ‚Π΅ΠΉ, Ρ‚Π°ΠΊ ΠΈ срСди взрослых. ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½Ρ‹ клиничСскиС особСнности тСчСния ΠΈ классификации ΠžΠ Π’Π˜, гСрпСтичСских ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΉ, ΠΈΠΌΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰ΠΈΡ… ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², Π° Ρ‚Π°ΠΊΠΆΠ΅ возмоТности соврСмСнного лСчСния с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡƒΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Π°, особСнно у часто Π±ΠΎΠ»Π΅ΡŽΡ‰ΠΈΡ… Π΄Π΅Ρ‚Π΅ΠΉ ΠΈ взрослых

    ΠŸΠΠΠ”Π•ΠœΠ˜Π§Π•Π‘ΠšΠ˜Π™ Π“Π Π˜ΠŸΠŸ A (H1N1) PDM 09 Π’ Π­ΠŸΠ˜Π”Π‘Π•Π—ΠžΠ 2015/2016 Π“Π“.: ΠΠΠΠ›Π˜Π— ЛЕВАЛЬНЫΠ₯ ИБΠ₯ΠžΠ”ΠžΠ’ Π£ Π”Π•Π’Π•Π™

    Get PDF
    The analysis of the characteristics of the current influenza A(H1N1) pdm 09 at 624 children in the 2015/2016 season. For severe illness (5%) characterized by short incubation period, lack of initial period, acute or acute onset with rapid development of multiorgan failure, prolonged febrile body temperature (up to 5β€”6 days or more) in the absence of complications, a prolonged severe intoxication (4β€”5 days or more), a significant frequency of diarrhea syndrome (10,2%), hemorrhagic syndrome (5.3%), exacerbation of comorbidity (20%), combinedΒ  with other viral infectionsΒ  β€” herpes, rotavirus, enterovirus and others (33%).In the clinical analysis of blood β€” leukopenia (33.9%), leukocytosis (14.5%) with neutrophilicΒ  shift (11.3%), neutrophilia (51.6%), monocytosis (45.2%), lymphocytosis (9.7%), thrombocytopenia, anemia, accelerated erythrocyte sedimentation rate moderately; in the biochemical analysis of blood, hypernatremia, increase in the concentration of lactate, hyperfermentemia (ALT, AST, ALP, LDH, CPK), hypoproteinemia, dysproteinemia, increased CRP, increased creatinine and urea, increase of procalcitonin (PCT). In the structure of complications of pneumonia was 6%, stenosing laryngotracheitis β€” 9.8%, obstructive bronchitis β€” 14.5%. Two unvaccinated against influenza in infants who become ill during the epidemic period for influenza and SARS from homes with a typical clinical picture, died from severe (toxic) form of pandemic influenza. Pandemic influenza occurred at the background of severe immunosuppression (atrophy of the thymus, depletionΒ  of follicles of peripheral organs of immunogenesis β€” spleen, lymph nodes, tonsils). The main cause of death was the development of multiple organ failure with rapid progressive lesion of the vital organs.Β ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· особСнностСй тСчСния Π³Ρ€ΠΈΠΏΠΏΠ° A (H1N1) pdm 09 Ρƒ 624 Π΄Π΅Ρ‚Π΅ΠΉ Π² эпидсСзон 2015/2016 Π³Π³. ΠŸΡ€ΠΈ тяТСлой Ρ„ΠΎΡ€ΠΌΠ΅ Π±ΠΎΠ»Π΅Π·Π½ΠΈ (5%) ΠΎΡ‚ΠΌΠ΅Ρ‡Π°ΡŽΡ‚ΡΡ: ΠΊΠΎΡ€ΠΎΡ‚ΠΊΠΈΠΉ ΠΈΠ½ΠΊΡƒΠ±Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄, отсутствиС Π½Π°Ρ‡Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π°, остроС ΠΈΠ»ΠΈ ΠΎΡΡ‚Ρ€Π΅ΠΉΡˆΠ΅Π΅ Π½Π°Ρ‡Π°Π»ΠΎ с быстрым Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ΠΌ ΠΏΠΎΠ»ΠΈΠΎΡ€Π³Π°Π½Π½ΠΎΠΉ нСдостаточности, Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ Ρ„Π΅Π±Ρ€ΠΈΠ»ΡŒΠ½Π°Ρ Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€Π° Ρ‚Π΅Π»Π° (Π΄ΠΎ 5β€”6 суток ΠΈ Π±ΠΎΠ»Π΅Π΅) ΠΏΡ€ΠΈ отсутствии ослоТнСний,Β  выраТСнная Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ интоксикация (4β€”5 суток ΠΈ Π±ΠΎΠ»Π΅Π΅), Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ частота синдрома Π΄ΠΈΠ°Ρ€Π΅ΠΈ (10,2%), Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ гСморрагичСского синдрома (5,3%), обострСниС ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰Π΅ΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ (20%), сочСтаниС с Π΄Ρ€ΡƒΠ³ΠΈΠΌΠΈ вирусными инфСкциями β€” гСрпСсвирусной, ротавирусной, энтСровирусной ΠΈ Π΄Ρ€. (33%).Π’ клиничСском  Π°Π½Π°Π»ΠΈΠ·Π΅ ΠΊΡ€ΠΎΠ²ΠΈ ΠΎΡ‚ΠΌΠ΅Ρ‡Π°ΡŽΡ‚ΡΡ лСйкопСния (33,9%), Π»Π΅ΠΉΠΊΠΎΡ†ΠΈΡ‚ΠΎΠ· (14,5%) с Π½Π΅ΠΉΡ‚Ρ€ΠΎΡ„ΠΈΠ»ΡŒΠ½Ρ‹ΠΌ сдвигом (11,3%), Π½Π΅ΠΉΡ‚Ρ€ΠΎΡ„ΠΈΠ»Π΅Π· (51,6%), ΠΌΠΎΠ½ΠΎΡ†ΠΈΡ‚ΠΎΠ· (45,2%), Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ· (9,7%), тромбоцитопСния, анСмия, ΡƒΠΌΠ΅Ρ€Π΅Π½Π½ΠΎ ускорСнная БОЭ; Π² биохимичСском Π°Π½Π°Π»ΠΈΠ·Π΅ ΠΊΡ€ΠΎΠ²ΠΈΒ  β€” гипСрнатриСмия, нарастаниС ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΈ Π»Π°ΠΊΡ‚Π°Ρ‚Π°, гипСрфСрмСнтСмия (АЛВ, АБВ, Π©Π€, Π›Π”Π“, КЀК), гипопротСинСмия, диспротСинСмия, ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ Π‘Π Π‘, ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ ΠΊΡ€Π΅Π°Ρ‚ΠΈΠ½ΠΈΠ½Π° ΠΈ ΠΌΠΎΡ‡Π΅Π²ΠΈΠ½Ρ‹, ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ ΠΏΡ€ΠΎΠΊΠ°Π»ΡŒΡ†ΠΈΡ‚ΠΎΠ½ΠΈΠ½Π° (ПКВ). Π’ структурС  ослоТнСний  ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈΒ  составили 6%, ΡΡ‚Π΅Π½ΠΎΠ·ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠ΅ Π»Π°Ρ€ΠΈΠ½Π³ΠΎΡ‚Ρ€Π°Ρ…Π΅ΠΈΡ‚Ρ‹Β  β€”Β  9,8%, обструктивныС   Π±Ρ€ΠΎΠ½Ρ…ΠΈΡ‚Ρ‹Β  β€” 14,5%. Π”Π²ΠΎΠ΅ Π½Π΅ΠΏΡ€ΠΈΠ²ΠΈΡ‚Ρ‹Ρ… ΠΏΡ€ΠΎΡ‚ΠΈΠ² Π³Ρ€ΠΈΠΏΠΏΠ° Π΄Π΅Ρ‚Π΅ΠΉ Ρ€Π°Π½Π½Π΅Π³ΠΎ возраста, заболСвшиС Π² эпидСмичСский ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ ΠΏΠΎ Π³Ρ€ΠΈΠΏΠΏΡƒ, ΠΈΠ· сСмСйных ΠΎΡ‡Π°Π³ΠΎΠ² ΠžΠ Π’Π˜, с Ρ‚ΠΈΠΏΠΈΡ‡Π½ΠΎΠΉ клиничСской ΠΊΠ°Ρ€Ρ‚ΠΈΠ½ΠΎΠΉ, ΡƒΠΌΠ΅Ρ€Π»ΠΈ ΠΎΡ‚ тяТСлой (токсичСской) Ρ„ΠΎΡ€ΠΌΡ‹ пандСмичСского Π³Ρ€ΠΈΠΏΠΏΠ°. ΠŸΠ°Π½Π΄Π΅ΠΌΠΈΡ‡Π΅ΡΠΊΠΈΠΉ Π³Ρ€ΠΈΠΏΠΏ ΠΏΡ€ΠΎΡ‚Π΅ΠΊΠ°Π» Π½Π° Ρ„ΠΎΠ½Π΅ Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½ΠΎΠΉ иммуносупрСссии (атрофия тимуса, истощСниС Ρ„ΠΎΠ»Π»ΠΈΠΊΡƒΠ»ΠΎΠ² пСрифСричСских ΠΎΡ€Π³Π°Π½ΠΎΠ² ΠΈΠΌΠΌΡƒΠ½ΠΎΠ³Π΅Π½Π΅Π·Π° β€” сСлСзСнки, лимфатичСских ΡƒΠ·Π»ΠΎΠ², ΠΌΠΈΠ½Π΄Π°Π»ΠΈΠ½). Основной ΠΏΡ€ΠΈΡ‡ΠΈΠ½ΠΎΠΉ смСрти явилось Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ ΠΏΠΎΠ»ΠΈΠΎΡ€Π³Π°Π½Π½ΠΎΠΉ нСдостаточности с быстрым ΠΏΡ€ΠΎΠ³Ρ€Π΅ΡΡΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΌ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎ Π²Π°ΠΆΠ½Ρ‹Ρ… ΠΎΡ€Π³Π°Π½ΠΎΠ²

    EFFEKTIVNOST' I BEZOPASNOST' ANAL'GETIChESKOY TERAPII ETORIKOKSIBOM U PATsIENTOV S OSTEOARTROZOM I KOMORBIDNOST'Yu

    No full text
    Π’ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ ΠΈΠΌΠ΅ΡŽΡ‚ΡΡ ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΡ€Π΅Ρ‡ΠΈΠ²Ρ‹Π΅ Π΄Π°Π½Π½Ρ‹Π΅ ΠΎ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠΈ ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ риска сСрдСчно-сосудистых ослоТнСний ΠΈ ΡƒΡ…ΡƒΠ΄ΡˆΠ΅Π½ΠΈΠΈ контроля Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅Ρ€Ρ‚Π΅Π½Π·ΠΈΠΈ (АГ) ΠΏΡ€ΠΈ Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ эторикоксибом, Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π½Ρ‹ΠΌ Π² 1990-Π΅ Π³ΠΎΠ΄Ρ‹ для сниТСния риска ΡΠ΅Ρ€ΡŒΠ΅Π·Π½Ρ‹Ρ… Π³Π°ΡΡ‚Ρ€ΠΎΠΈΠ½Ρ‚Π΅ΡΡ‚ΠΈΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΠΎΠ±ΠΎΡ‡Π½Ρ‹Ρ… эффСктов нСсСлСктивных нСстСроидных ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ² (ΠΠŸΠ’ΠŸ), ΠΏΡ€ΠΈΡ‡Π΅ΠΌ Π½Π΅ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ источники ΡƒΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚, Ρ‡Ρ‚ΠΎ ΠΎΡ‚Ρ€ΠΈΡ†Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ влияниС коксибов Π½Π° ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ АГ Π½Π°Π±Π»ΡŽΠ΄Π°Π΅Ρ‚ΡΡ ΠΈ ΠΏΡ€ΠΈ ΠΈΡ… постоянном ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠΈ, ΠΈ ΠΏΡ€ΠΈ ΠΏΡ€ΠΈΠ΅ΠΌΠ΅ ΠΏΠΎ Ρ‚Ρ€Π΅Π±ΠΎΠ²Π°Π½ΠΈΡŽ. Однако Π² нашСй клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅ Π±Ρ‹Π»ΠΎ Π·Π°ΠΌΠ΅Ρ‡Π΅Π½ΠΎ, Ρ‡Ρ‚ΠΎ Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ эторикоксибом нСчасто ΠΏΡ€ΠΈΠ²ΠΎΠ΄ΠΈΡ‚ ΠΊ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡŽ срСднСго Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ давлСния (АД) ΠΈΠ»ΠΈ возникновСнию сСрдСчно-сосудистых катастроф. ЦСль. ΠžΡ†Π΅Π½ΠΈΡ‚ΡŒ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Π°Π½Π°Π»ΡŒΠ³Π΅Π·ΠΈΡ€ΡƒΡŽΡ‰Π΅Π³ΠΎ дСйствия эторикоксиба, частоту развития Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… явлСния ΠΈ дСкомпСнсации ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Π½Π° Ρ„ΠΎΠ½Π΅ Π΅Π³ΠΎ ΠΏΡ€ΠΈΠ΅ΠΌΠ° Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с остСоартрозом (ОА). ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Под наблюдСниСм Π½Π°Ρ…ΠΎΠ΄ΠΈΠ»ΠΈΡΡŒ 26 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ОА (12 ΠΌΡƒΠΆΡ‡ΠΈΠ½ ΠΈ 14 ΠΆΠ΅Π½Ρ‰ΠΈΠ½) Π² возрастС ΠΎΡ‚ 53 Π΄ΠΎ 70 Π»Π΅Ρ‚ (срСдний возраст 60,38Β±5,48) со срСднСй Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒΡŽ заболСвания 7,62Β±5,8 Π»Π΅Ρ‚. 20 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² (76,9%) ΠΈΠΌΠ΅Π»ΠΈ Π±ΠΎΠ»ΠΈ Π² спинС, 26 (100%) - Π² ΠΊΠΎΠ»Π΅Π½Π½ΠΎΠΌ суставС, 20 (100%) - Π² Ρ‚Π°Π·ΠΎΠ±Π΅Π΄Ρ€Π΅Π½Π½ΠΎΠΌ, 4 (15,38%) - Π² шСС, 2 (7,7%) - Π² ΠΌΠ΅Π»ΠΊΠΈΡ… суставах. ΠŸΡ€ΠΈ этом 22 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° (84,6%) ΠΈΠΌΠ΅Π»ΠΈ ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠ΅ заболСвания (ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡Π½ΠΎ-ΠΊΠΈΡˆΠ΅Ρ‡Π½ΠΎΠ³ΠΎ Ρ‚Ρ€Π°ΠΊΡ‚Π° - 30,7%, АГ - 84,6%). Π”ΠΎ ΠΌΠΎΠΌΠ΅Π½Ρ‚Π° обращСния всС ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ ΠΏΠΎΠ»ΡƒΡ‡Π°Π»ΠΈ ΠΠŸΠ’ΠŸ (Π΄ΠΈΠΊΠ»ΠΎΡ„Π΅Π½Π°ΠΊ, нимСсулид, ΠΊΠ΅Ρ‚ΠΎΠΏΡ€ΠΎΡ„Π΅Π½, мСлоксикам, Π°Ρ†Π΅ΠΊΠ»ΠΎΡ„Π΅Π½Π°ΠΊ, ΠΈΠ±ΡƒΠΏΡ€ΠΎΡ„Π΅Π½) с Π½Π΅ΡƒΠ΄ΠΎΠ²Π»Π΅Ρ‚Π²ΠΎΡ€ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ (69,2%) ΠΈΠ»ΠΈ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡŒΠ½Ρ‹ΠΌ эффСктом (23,07%). ВсСм Π±ΠΎΠ»ΡŒΠ½Ρ‹ΠΌ Π±Ρ‹Π» Π½Π°Π·Π½Π°Ρ‡Π΅Π½ эторикоксиб ΠΏΠΎ Ρ‚Ρ€Π΅Π±ΠΎΠ²Π°Π½ΠΈΡŽ Π² Π΄ΠΎΠ·Π΅ 60 ΠΈΠ»ΠΈ 90 ΠΌΠ³/ сут. Π’ Π½Π°Ρ‡Π°Π»Π΅ ΠΈ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 1 мСсяца лСчСния ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡŒ ΠΎΡ†Π΅Π½ΠΊΠ° выраТСнности Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ синдрома ΠΏΠΎ Π²ΠΈΠ·ΡƒΠ°Π»ΡŒΠ½ΠΎ-Π°Π½Π°Π»ΠΎΠ³ΠΎΠ²ΠΎΠΉ шкалС (ВАШ), состояния ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰Π΅ΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ, уровня АД. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π‘Ρ€Π΅Π΄Π½ΠΈΠΉ Π²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΈΠ½Ρ‚Π΅Ρ€Π²Π°Π» ΠΌΠ΅ΠΆΠ΄Ρƒ двумя осмотрами составил 22,3Β±8,05 Π΄Π½Π΅ΠΉ. На ΠΌΠΎΠΌΠ΅Π½Ρ‚ Π²Ρ‚ΠΎΡ€ΠΎΠ³ΠΎ Π²ΠΈΠ·ΠΈΡ‚Π° 84,6% ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΏΡ€ΠΈΠ΄Π΅Ρ€ΠΆΠΈΠ²Π°Π»Π°ΡΡŒ Π½Π°Π·Π½Π°Ρ‡Π΅Π½Π½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ, ΠΏΡ€ΠΈ этом Π±Ρ‹Π»Π° ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½Π° Ρ…ΠΎΡ€ΠΎΡˆΠ°Ρ ΠΏΠ΅Ρ€Π΅Π½ΠΎΡΠΈΠΌΠΎΡΡ‚ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° (76,9% отличная, 23,07% ΡƒΠ΄ΠΎΠ²Π»Π΅Ρ‚Π²ΠΎΡ€ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ). Π˜Π½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ синдрома ΠΏΠΎ ВАШ Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ‚ ΠΏΠ΅Ρ€Π²ΠΎΠ³ΠΎ осмотра составила 6,84Β±0,98, ΠΏΡ€ΠΈ Π²Ρ‚ΠΎΡ€ΠΎΠΌ - 2,53Β±1,05, ΠΏΡ€ΠΈ этом наибольшСС ΡƒΠΌΠ΅Π½ΡŒΡˆΠ΅Π½ΠΈΠ΅ Π΄Π°Π½Π½ΠΎΠ³ΠΎ показатСля наблюдалось Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ΠΌ заболСвания (Π±ΠΎΠ»Π΅Π΅ 3 Π»Π΅Ρ‚) - с 7Β±1,08 Π΄ΠΎ 2,5Β±0,97. ПолноС ΠΊΡƒΠΏΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΠΎΠ»ΠΈ ΠΎΡ‚ΠΌΠ΅Ρ‚ΠΈΠ»ΠΈ 100% ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с болью ΠΌΠ΅Π»ΠΊΠΈΡ… суставах ΠΈ 50% ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с болью Π² Ρ‚Π°Π·ΠΎΠ±Π΅Π΄Ρ€Π΅Π½Π½Ρ‹Ρ… суставах ΠΈ Π² шСС, сниТСниС Π±ΠΎΠ»ΠΈ Π±ΠΎΠ»Π΅Π΅ Ρ‡Π΅ΠΌ Π½Π° 50% выявлСно Ρƒ 76,9% с болью Π² ΠΊΠΎΠ»Π΅Π½Π½Ρ‹Ρ… суставах ΠΈ 35,78% ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с болью Π² спинС. НС ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½ΠΎ случаСв обострСния язвСнной Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΈ Π·Π½Π°Ρ‡ΠΈΠΌΠΎΠ³ΠΎ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ АД Π½Π° Ρ„ΠΎΠ½Π΅ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ, Π² Ρ‚ΠΎΠΌ числС ΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с АГ. Π’Ρ‹Π²ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ эторикоксиба Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ОА ΠΏΡ€ΠΈΠ²ΠΎΠ΄ΠΈΡ‚ ΠΊ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΌΡƒ ΡƒΠΌΠ΅Π½ΡŒΡˆΠ΅Π½ΠΈΡŽ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ синдрома, особСнно Π² ΠΌΠ΅Π»ΠΊΠΈΡ… суставах ΠΈ Ρ‚Π°Π·ΠΎΠ±Π΅Π΄Ρ€Π΅Π½Π½Ρ‹Ρ… суставах, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΏΡ€ΠΈ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΌ Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠΈ заболСвания, Π±Π΅Π· ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ срСднСго АД ΠΈ обострСния хроничСских ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ
    • …
    corecore